Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study, Journal of Neurodevelopmental Disorders, December 2015, Springer Science + Business Media,
DOI: 10.1186/s11689-015-9134-5.
You can read the full text:
Contributors
The following have contributed to this page